CME Group (CME Group) Cash And Cash Equivalents : $2,912 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CME Group Cash And Cash Equivalents?

CME Group's quarterly cash and cash equivalents increased from Jun. 2023 ($1,880.10 Mil) to Sep. 2023 ($2,300.20 Mil) and increased from Sep. 2023 ($2,300.20 Mil) to Dec. 2023 ($2,912.00 Mil).

CME Group's annual cash and cash equivalents declined from Dec. 2021 ($2,834.90 Mil) to Dec. 2022 ($2,720.10 Mil) but then increased from Dec. 2022 ($2,720.10 Mil) to Dec. 2023 ($2,912.00 Mil).

CME Group Cash And Cash Equivalents Historical Data

The historical data trend for CME Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Cash And Cash Equivalents Chart

CME Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,551.40

1,633.20

2,834.90

2,720.10

2,912.00

CME Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															2,720.10	1,565.20	1,880.10	2,300.20	2,912.00

CME Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

CME Group (NAS:CME) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

CME Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of CME Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

CME Group (CME Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

CME:Mexico MX4A:Germany MX4A:Germany CHME34:Brazil

Address

20 South Wacker Drive, Chicago, IL, USA, 60606

Website

https://www.cmegroup.com

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Executives

William R Shepard	director	20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin	officer: MD & COO	20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann	officer: Managing Dir Financial Product	20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague	officer: Sr MD Global Head of Clearing	20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt	officer: Sr MD Global Head Equity & FX	20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman	director	20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy	director	20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter	officer: MD Operations	20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger	director	20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler	officer: Chief Commercial Officer	20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman	director	20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell	officer: MD, Organizational Development	20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho	officer: President, CME Clearing	20 S. WACKER DR., CHICAGO IL 60606